Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy

European Journal of Pediatrics

Volumn 160, Issue 6, 2001, Pages 401-

  Ito, Tadahiko ^a   Shibata, Keiichi ^a   Watanabe, Arata ^a   Akabane, Jinzo ^a  

^a NAKADORI GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE;

ADOLESCENT; ARTICLE; BRAIN DISEASE; CASE REPORT; DOPAMINERGIC ACTIVITY; DRUG WITHDRAWAL; HUMAN; INFLUENZA VIRUS A; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; AMANTADINE; ANTIVIRAL AGENTS; BRAIN DISEASES; DOPAMINE ANTAGONISTS; HUMANS; INFLUENZA, HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0035026980     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310100743     Document Type: Article

References (6)

1. 1. Henderson VW, Wooten GF (1981) Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade? Neurology 31: 132-135
2. 2. Lazarus A (1985) Neuroleptic malignant syndrome and amantadine withdrawal. Am J Psychiatry 142: 142
3. 3. Morris HH, McCormick WF (1980) Neuroleptic malignant syndrome. Arch Neurol 37: 462-465
4. 4. Simpson DM, Davis GC (1984) Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine. Am J Psychiatry 141: 796-797
5. 5. Tominack RL, Hayden FG (1987) Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin N Am 47: 459-478
6. 6. Toru M, Matsuda O (1981) Neuroleptic malignant syndrome-like state following a withdrawal of anti-parkinsonian drugs. J Nerv Ment Dis 169: 324-327